4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-22-001631
Chief Financial Officer acquired 33,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-11 | Grant or award : show line 1 in the form | +33,000 | $0.31 | $10,230 | 184,500 | D |
Loading xslF345X03/ownership.xml…